Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma.
about
Murine models and cell lines for the investigation of pheochromocytoma: applications for future therapies?Connecting molecular pathways to hereditary cancer risk syndromesCurrent views on cell metabolism in SDHx-related pheochromocytoma and paragangliomaA new specific succinate-glutamate metabolomic hallmark in SDHx-related paragangliomas.Association of urinary bladder paragangliomas with germline mutations in the SDHB and VHL genes.Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography.Neurofibromatosis-related phaeochromocytoma: two cases with large tumours and elevated plasma methoxytyramine.The genetic basis of pheochromocytoma and paraganglioma: implications for managementSubclinical phaeochromocytoma.Phaeochromocytoma: a catecholamine and oxidative stress disorder.Pheochromocytoma - update on disease management.Genetic screening for von Hippel-Lindau gene mutations in non-syndromic pheochromocytoma: low prevalence and false-positives or misdiagnosis indicate a need for caution.Molecular and therapeutic advances in the diagnosis and management of malignant pheochromocytomas and paragangliomasDouble stable isotope ultra performance liquid chromatographic-tandem mass spectrometric quantification of tissue content and activity of phenylethanolamine N-methyltransferase, the crucial enzyme responsible for synthesis of epinephrineGenotype-specific abnormalities in mitochondrial function associate with distinct profiles of energy metabolism and catecholamine content in pheochromocytoma and paraganglioma.Plasma-free vs deconjugated metanephrines for diagnosis of phaeochromocytomaRole of hypoxia and HIF2α in development of the sympathoadrenal cell lineage and chromaffin cell tumors with distinct catecholamine phenotypic features.Hypoxia-inducible factor signaling in pheochromocytoma: turning the rudder in the right direction.Diagnostic tests and biomarkers for pheochromocytoma and extra-adrenal paraganglioma: from routine laboratory methods to disease stratification.Screening for pheochromocytomas and paragangliomas.Pathophysiology and diagnosis of disorders of the adrenal medulla: focus on pheochromocytoma.Genetic status determines (18) F-FDG uptake in pheochromocytoma/paraganglioma.PheoSeq: A Targeted Next-Generation Sequencing Assay for Pheochromocytoma and Paraganglioma Diagnostics.Update on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine Tumours.Pheochromocytomas and paragangliomas in humans and dogs.Novel insights into the polycythemia-paraganglioma-somatostatinoma syndrome.Integrated whole-body PET/MRI with 18F-FDG, 18F-FDOPA, and 18F-FDA in paragangliomas in comparison with PET/CT: NIH first clinical experience with a single-injection, dual-modality imaging protocol.Pheochromocytoma: The First Metabolic Endocrine Cancer.Novel germline SDHD mutation: diagnosis and implications to the patient.Role of rapid sequence whole-body MRI screening in SDH-associated hereditary paraganglioma families.The impact of changes in drug availability for hemodynamic management in pheochromocytoma: prêt-à-porter or tailor-made?New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification.Metabologenomics of Phaeochromocytoma and Paraganglioma: An Integrated Approach for Personalised Biochemical and Genetic Testing.Quantitative 18F-DOPA PET/CT in pheochromocytoma: the relationship between tumor secretion and its biochemical phenotype.New Insights into the Nuclear Imaging Phenotypes of Cluster 1 Pheochromocytoma and Paraganglioma.[Mutations in succinate dehydrogenase and DNA methylation].Integrative genomics reveals frequent somatic NF1 mutations in sporadic pheochromocytomasIntegrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma
P2860
Q26828446-99B972C8-BDC5-4C91-ACD7-05204EB10462Q28291516-FC986398-4AD9-455B-8848-6B7594E0571CQ33590969-80CB7670-F472-4349-9434-566AEBDD6BD5Q35060334-12C809A0-1E20-4D3F-89B4-73D04BADEA7CQ35562799-773AF605-9CBA-4F35-A446-6461B07A497BQ35925505-C3B10ACB-0961-44F1-9C93-0F9568D89F3CQ35942899-1D177326-EFDF-4690-9CCF-4A4923DA74A9Q36067684-AE994AD8-DB1C-4168-A52A-A6609D7BE393Q36145100-42B317EC-D695-4D5E-9965-3B8CB39099E4Q36149357-362C2718-C51F-40D6-91F1-DEFE048F0876Q36328071-A1E5416A-99F1-4BD9-AE87-0FC01004FDF5Q36408983-522ED883-F284-4C43-98D5-EE67429FCC40Q36804496-330449B9-C91D-45C4-BF3C-C3946475BD4CQ36898863-EDD442D6-EA4A-44FC-B4B6-72C54F81DED2Q37025126-5D5CE584-E61E-47C4-B422-9E481A455298Q37146776-002F4766-F1DA-4781-A738-1EA85264F1C5Q37202015-CC7011CF-DEEA-4818-81B5-EADEB00BEA2FQ37464073-8418E5AE-28C4-4BD2-A4B9-2735C5F0A194Q37969708-7974CB3E-73A9-45F8-BE3C-720561C713EBQ37976969-93A8F0A7-BE68-433C-84F4-8CF0375FC0C0Q38203226-A21A9406-DD44-4DB8-B84A-46CC7F16ECAAQ38741404-72E72C10-EF8E-44AA-BD07-89D98D21FC1CQ38759395-82474B65-B347-4F9E-BF8C-D91EE72931FDQ38801063-3124D3FE-EBEC-4D15-B256-EAB4FB5A2F00Q39102360-3B94151B-6511-4F4B-BB19-FAA041B0680FQ40495238-B1E2A4DE-6F3E-4FF0-AD84-026602D5CCF2Q41207387-DC46F8EF-9BE3-480B-92A2-BCC0F4B6C49BQ42197171-399282E0-F9CE-4E3B-B72F-E3FCA87744FDQ42750863-2772786F-5FB3-41BB-96D8-C9810A7A55C4Q43868407-27298CDF-89E4-44DB-88FF-2438F5FFF6C0Q46889690-8E912F8E-E42C-41DE-9E75-C8B6CB331319Q47934716-81BA9945-A68F-44E6-A444-6A680810E3ECQ49174438-571ECCB8-A628-4873-BC60-9834B3D3E019Q50055564-836E81E3-08C3-4862-9249-29B466020F64Q50229413-EDDD574A-7B10-4645-86C5-2E03160B2DBAQ54415830-05843D87-67B1-44FB-B804-C1CC3EEC5E8BQ56697959-963C5859-F393-4C94-B0C4-0D69C72D0280Q57817523-A7A5F190-3712-4A69-B8DC-CAA3C4D5A544
P2860
Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma.
@en
type
label
Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma.
@en
prefLabel
Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma.
@en
P2093
P2860
P356
P1476
Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma.
@en
P2093
Gennady Bratslavsky
Graeme Eisenhofer
Henri J Timmers
Jacques W M Lenders
Massimo Mannelli
Peter Friberg
Stefan K Grebe
Thanh-Truc Huynh
W Marston Linehan
P2860
P304
P356
10.1677/ERC-10-0211
P577
2010-12-21T00:00:00Z